Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.470
+0.050 (3.52%)
Feb 13, 2026, 4:00 PM EST - Market closed
Pulmonx Revenue
Pulmonx had revenue of $21.50M in the quarter ending September 30, 2025, with 5.47% growth. This brings the company's revenue in the last twelve months to $91.66M, up 15.59% year-over-year. In the year 2024, Pulmonx had annual revenue of $83.79M with 22.01% growth.
Revenue (ttm)
$91.66M
Revenue Growth
+15.59%
P/S Ratio
0.65
Revenue / Employee
$314,997
Employees
291
Market Cap
60.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 83.79M | 15.11M | 22.01% |
| Dec 31, 2023 | 68.68M | 15.01M | 27.98% |
| Dec 31, 2022 | 53.66M | 5.25M | 10.84% |
| Dec 31, 2021 | 48.42M | 15.68M | 47.91% |
| Dec 31, 2020 | 32.73M | 138.00K | 0.42% |
| Dec 31, 2019 | 32.60M | 12.59M | 62.94% |
| Dec 31, 2018 | 20.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Xtant Medical Holdings | 133.08M |
| Outset Medical | 119.48M |
| MaxCyte | 34.42M |
| electroCore | 29.84M |
| Sensus Healthcare | 27.48M |
| Spectral AI | 23.17M |
| Elutia | 21.75M |
LUNG News
- 2 months ago - Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Pulmonx Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 - GlobeNewsWire
- 4 months ago - Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025 - GlobeNewsWire
- 6 months ago - Pulmonx to Participate in September Investor Conferences - GlobeNewsWire
- 7 months ago - Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Pulmonx Reports Second Quarter 2025 Financial Results - GlobeNewsWire